Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin

da Silveira, MMBM; Melo, LD; Gomes, FMF; Andrade, LJDBD; Serur, IP; Piscoya, ICD; Gueiros, RM; do O, KP; de Lima, RE; Brasileiro, VAE; Vasconcelos, LRS; Sobral, DC

da Silveira, MMBM (reprint author), Univ Pernambuco, FCM UPE, Fac Ciencias Med, Palmares St, BR-07497024 Recife, PE, Brazil.

APPLICATION OF CLINICAL GENETICS, 2019; 12 (): 151

Abstract

Introduction: Warfarin continues to be the most widely used anticoagulant in clinical practice around the world for the prevention of thromboembolic e......

Full Text Link